The global Foley Catheters Market, valued at US$895.0 million in 2024, stood at US$931.0 million in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2030, culminating in a forecasted valuation of US$1,205.0 million by the end of the period. This growth is driven by several factors, including the increasing prevalence of urinary incontinence, kidney and bladder disorders, and prostate-related conditions, particularly among the aging population. Additionally, the rise in surgical procedures performed in hospitals and ambulatory surgical centers is contributing to consistent demand for Foley catheters, as they are commonly used for perioperative care and post-surgical recovery.
Furthermore, the expansion of healthcare access in emerging economies is creating new opportunities for market growth. Technological advancements, such as antimicrobial coatings and infection-prevention designs, are also encouraging the preference for higher-quality products. Together, these factors are establishing a steady growth trajectory for the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166415161
By coating type, the Foley catheters market is categorized into antimicrobial-coated Foley catheters, hydrophilic or lubrication-coated Foley catheters, and uncoated Foley catheters. In 2024, the antimicrobial-coated Foley catheters segment held the largest market share. This growth is primarily driven by the increasing focus on reducing catheter-associated urinary tract infections (CAUTIs), which continue to be a significant concern in hospitals and surgical centers. Antimicrobial catheters offer clear clinical benefits by enhancing patient safety and decreasing infection-related costs, making them the preferred option for healthcare providers.
Market players can capitalize on this strong demand by expanding their line of coated products, investing in evidence-based studies to showcase clinical outcomes, and collaborating with hospitals to incorporate these solutions into infection prevention protocols. This approach will strengthen adoption and help establish a long-term competitive advantage in the market.
By gender, the Foley catheters market is divided into males and females. The market for males category is expected to experience the highest CAGR during the forecast period. This growth is primarily driven by the increasing prevalence of prostate enlargement, urinary retention, and bladder dysfunction, especially among older men.
Moreover, there is a growing awareness and diagnosis of urological conditions, coupled with an increasing need for long-term catheterization in chronic cases, which further fuels this demand. Market players can capitalize on this trend by developing specialized catheters designed specifically for male anatomies, emphasizing comfort, reduced infection risk, and ease of use. Additionally, enhancing clinical education and forming partnerships with urologists will also help drive adoption and ensure sustained market growth.
By geography, the Foley catheters market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with Europe holding the largest share in 2024. This is due to its well-established healthcare infrastructure, high surgical volumes, and an aging population vulnerable to urological issues.
As of January 1, 2024, the EU population was around 449.3 million, with 21.6% aged 65 and older, particularly in countries like Italy and Portugal. The region’s focus on infection prevention has increased the demand for coated and antimicrobial catheters. Government reimbursement and public insurance also support costs for seniors and long-term patients.
Increased awareness of incontinence; the presence of major players such as B. Braun SE, Medtronic Plc, and Optimum Medical Limited; and ongoing product innovations further drive market growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166415161
Some of the prominent players operating in the market include Coloplast A/S (Denmark), Becton, Dickinson and Company (US), Cardinal Health, Inc. (US), Teleflex Incorporated (US), Medtronic Plc (Ireland), Sterimed Group (India), Medline Industries, LP (US), Amsino International, Inc. (US), B. Braun SE (Germany), Bactiguard AB (US), and McKesson Corporation (US).
